Customized Peptide Synthesis Market Research Report 2024

Customized Peptide Synthesis Market Size to Reach $390 Million by 2024 www.psmarketresearch.com

Customized Peptide Synthesis Market

Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology.

Explore report at: https://www.psmarketresearch.com/market-analysis/customized-peptidesynthesis-market

“ Copyright Š P&S Intelligence

Customized Peptide Synthesis Market The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected to observe faster growth in demand, witnessing a CAGR of 6.8% during the forecast period. This growth can be attributed to the high usage of a wide range of reagents including substrates, additives, buffers, precipitation agents, and others for the purpose of peptide synthesis.

Among the various applications, commercial application is the fastest growing category in the customized peptide synthesis industry, demonstrating a CAGR of 6.9% during the forecast period.

The recent advancements in chemical peptide synthesis and inclusion of modified amino acids have increased the commercial potential of customized peptides.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiryurl=customized-peptide-synthesis-market

Copyright Š P&S Intelligence

Customized Peptide Synthesis Market During the forecast period, customized peptide synthesis market in APAC is expected to witness the fastest growth, observing a CAGR of 7.9%. The growth in the market is mainly led by the increasing use of peptides in drug discovery, low cost of raw materials, technological advancements, increasing life sciences research activities, and availability of funds for research and development.

Additionally, increase in the sale of drugs derived from peptides has attracted interest of drug manufacturers toward the development of innovative and advanced products for treating chronic diseases. For instance, China Medical System Holdings Limited, developed XinHouSu, a recombinant human brain natriuretic peptide for injection, for treating acute heart failure.

XinHouSu, which is currently available only in China, recorded revenue of $62.3 million in 2017, witnessing an 18.9% increase compared to 2016 revenue.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/customizedpeptide-synthesis-market/report-sample

Copyright Š P&S Intelligence

Customized Peptide Synthesis Market

Globally, the customized peptide synthesis market is witnessing rapid evolution with the development and launch of new peptide-based products. For instance, in September 2018, Biotage AB launched its new Alstra remote software, which enables the users to program the peptide synthesis setup offline, subsequently import peptide sequences, and then execute the synthesis on Initiator + Alstra.

Some of the other key players operating in the customized peptide synthesis industry are GenScript Biotech Corporation, Bachem AG, Thermo Fisher Scientific Inc., AAPPTec LLC, Advanced ChemTech, AnaSpec Inc., New England Peptide Inc., Rockland Immunochemicals Inc., INTAVIS Bioanalytical Instruments AG, and JPT Peptide Technologies GmbH.

Copyright Š P&S Intelligence

THANK YOU! Click to edit Master title style For queries, kindly write to:

Edit Master text styles GET IN TOUCH

enquiry@psmarketresearch.com www.psmarketresearch.com B-13, Sector-2, Noida, U.P.-201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886

US/Canada Toll-Free: 1-888-778-7886

4/18/2019

6